Lil­ly to pay up to $415M in ALS deal; Ac­tu­ate’s mid-stage pan­cre­at­ic can­cer da­ta

3 days ago
News Briefing

Ex­clu­sive: Degra­da­tion start­up rais­es $39M for piv­ot to PRO­TACs and clin­i­cal en­try

3 days ago
People
Financing

Aldeyra plots third FDA fil­ing for dry eye dis­ease drug af­ter lat­est Phase 3 da­ta

3 days ago
R&D

Sin­ga­pore car­dio gene ther­a­py biotech col­lects $45M as it plots Eu­rope ex­pan­sion

4 days ago
Financing
Startups

Ver­tex touts promis­ing first few months of launch for non-opi­oid pain drug Jour­navx

4 days ago
Pharma

New opi­oid da­ta may not be gen­er­al­iz­able, FDA ad­comm says

4 days ago
Pharma
FDA+

FDA ad­comm will re­view Capri­cor's cell ther­a­py for Duchenne mus­cu­lar dy­s­tro­phy

4 days ago
Pharma
Cell/Gene Tx

PTC's Hunt­ing­ton’s study suc­ceeds, but ac­cel­er­at­ed ap­proval un­cer­tain

4 days ago
R&D

Bris­tol My­ers to lay off over 500 work­ers in New Jer­sey

4 days ago
People
Pharma

Even as ques­tions grow over RFK Jr.'s vac­cine pol­i­cy, BioN­Tech does­n't see ‘near-term’ im­pact

4 days ago
R&D
Pharma

Func­tion buys Ezra, cre­at­ing one-stop shop for pre­ven­tive test­ing and scans

4 days ago
Startups
Deals

Re­cur­sion cuts near­ly half of its pipeline, in­clud­ing its most ad­vanced pro­gram

4 days ago
R&D
AI

Uni­ty lays off 'al­l' work­ers; No­vo to get FDA de­ci­sion on oral We­govy this year

4 days ago
News Briefing

J&J's eye dis­ease gene ther­a­py bo­ta-vec fails in Phase 3 tri­al

4 days ago
R&D
Cell/Gene Tx

Iambic de­buts next ver­sion of AI mod­el En­chant, dri­ving new way for drug R&D

4 days ago
AI

Ex­clu­sive: Deer­field se­cures $600M+ for third health­care ven­ture fund to seed new com­pa­nies

4 days ago
Financing
Startups

Post-Hoc: The big ques­tion for the FDA af­ter Stealth’s PDU­FA de­lay

4 days ago
FDA+

Ear­ly bits of in vi­vo CAR-T hu­man da­ta emerge from biotech tri­als in Chi­na

4 days ago
R&D
China

Ex­clu­sive: Topas claims suc­cess in ear­ly test of 'im­mune tol­er­ance' ther­a­py for celi­ac dis­ease

5 days ago
R&D

Earn­ings sea­son con­tin­ues; FDA de­lays PDU­FA date; AACR re­cap; and more

6 days ago
Weekly

Ex­clu­sive: Ver­tex drops AAV gene ther­a­py re­search, tR­NA ther­a­py part­ner­ship

Last week
R&D
Cell/Gene Tx

Ex­clu­sive: Af­ter FDA fir­ings, drug re­view­ers are asked to vol­un­teer for ad­min­is­tra­tive work

Last week
FDA+

White House bud­get re­quest would cut bil­lions at NIH and CDC, add $500M for MA­HA

Last week
Pharma
FDA+

FDA with­draws two fi­nal guid­ances, pulls com­pli­ance dead­lines for bone al­lo­graft mak­ers

Last week
R&D
Pharma
First page Previous page 123456 Next page Last page
A service from the Financial Times